Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Guadecitabine

Generic Name: Guadecitabine

Drug Type: Small Molecule

Chemical Formula: C_₁₈H_₂₄N_₉O_₁₀P

CAS Number: 929901-49-5

Unique Ingredient Identifier: 2KT4YN1DP7

Overview

Guadecitabine is under investigation for the treatment of Previously Treated Metastatic Colorectal Cancer.

Background

Guadecitabine is under investigation for the treatment of Previously Treated Metastatic Colorectal Cancer.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Testing the Combination of Belinostat and SGI-110 (Guadecitabine) or ASTX727 for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma

Phase 2

Active, not recruiting

Posted: 2020/04/10

Sponsor:National Cancer Inst...

ID:NCT04340843

Guadecitabine in Combination With Carboplatin in Extensive Stage Small Cell Lung Cancer

Phase 2

Completed

Posted: 2019/04/12

Sponsor:

Shadia Jalal, MD

ID:NCT03913455

Guadecitabine Extension Study

Phase 2

Terminated

Posted: 2018/07/27

Sponsor:Astex Pharmaceutical...

ID:NCT03603964

Guadecitabine and Nivolumab in Treating Refractory Metastatic Colorectal Cancer

Phase 1

Withdrawn

Posted: 2018/07/05

Sponsor:University of Southe...

ID:NCT03576963

SGI-110 and Donor Lymphocyte Infusions (DLI) After Allogeneic Stem Cell Transplantation

Phase 2

Posted: 2018/03/06

Sponsor:Groupe Francophone d...

ID:NCT03454984

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy